The Committee recognized that there is very little scientific evidence to establish a level of difference in growth associated with long- or short- term health consequences. However, the Committee concluded that any systematic and statistically significant difference in size and growth rate among infants fed a formula with the new ingredient versus human milk or an already approved formula should be a safety concern.